A multigravid client at term is admitted for trial labor and possible vaginal birth. After receiving nalbuphine IV, fetal heart rate shows minimal variability at 120 bpm. The decreased variability is most likely caused by which factor?

A multigravid client at term is admitted for trial labor and possible vaginal birth. After receiving nalbuphine IV, fetal heart rate shows minimal variability at 120 bpm. The decreased variability is most likely caused by which factor?

• A. Fetal distress
• B. Effects of the analgesic medication
• C. Uteroplacental insufficiency
• D. Maternal hypotension

Answer: (B)

Fetal heart rate variability reflects the fetus’s autonomic nervous system activity and oxygenation status. It can be influenced by medications that cross the placenta and depress the fetal CNS. Nalbuphine, given IV for labor analgesia, crosses to the fetus and can cause mild fetal CNS depression, dampening autonomic fluctuations and producing decreased beat-to-beat variability. In this scenario, the baseline is within the normal range (120 bpm), and the decrease in variability occurs after administration of the analgesic, making the medication effect the most likely explanation. While fetal distress, uteroplacental insufficiency, or maternal hypotension can also affect variability, there are no decelerations or other distress signs described, and the recent analgesia points to its pharmacologic impact rather than a pathology.

Fetal heart rate variability reflects the fetus’s autonomic nervous system activity and oxygenation status. It can be influenced by medications that cross the placenta and depress the fetal CNS. Nalbuphine, given IV for labor analgesia, crosses to the fetus and can cause mild fetal CNS depression, dampening autonomic fluctuations and producing decreased beat-to-beat variability. In this scenario, the baseline is within the normal range (120 bpm), and the decrease in variability occurs after administration of the analgesic, making the medication effect the most likely explanation. While fetal distress, uteroplacental insufficiency, or maternal hypotension can also affect variability, there are no decelerations or other distress signs described, and the recent analgesia points to its pharmacologic impact rather than a pathology.